Used in research as a topoisomerase II inhibitor, showing potential antitumor activity. Investigated for its ability to induce DNA damage in cancer cells, leading to apoptosis. Demonstrates activity against various cancer cell lines, particularly in leukemia and solid tumor models. Its dimaleate salt form improves solubility and stability, aiding in experimental formulations. Not approved for clinical use but serves as a tool compound in oncology and pharmacology studies.